nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—HRH1—Cetirizine—allergic rhinitis	0.226	0.29	CbGbCtD
Tolazoline—Antazoline—Diphenhydramine—allergic rhinitis	0.214	1	CrCrCtD
Tolazoline—HRH1—Dimenhydrinate—allergic rhinitis	0.13	0.166	CbGbCtD
Tolazoline—HRH1—Desloratadine—allergic rhinitis	0.111	0.141	CbGbCtD
Tolazoline—HRH1—Olopatadine—allergic rhinitis	0.104	0.133	CbGbCtD
Tolazoline—HRH1—Cyproheptadine—allergic rhinitis	0.0838	0.107	CbGbCtD
Tolazoline—HRH1—Diphenhydramine—allergic rhinitis	0.0635	0.0812	CbGbCtD
Tolazoline—HRH1—Loratadine—allergic rhinitis	0.0635	0.0812	CbGbCtD
Tolazoline—HRH1—nose—allergic rhinitis	0.00126	0.366	CbGeAlD
Tolazoline—HRH2—skin of body—allergic rhinitis	0.000346	0.1	CbGeAlD
Tolazoline—HRH2—lung—allergic rhinitis	0.000231	0.0671	CbGeAlD
Tolazoline—ADRA1A—epithelium—allergic rhinitis	0.000179	0.0518	CbGeAlD
Tolazoline—ADRA2C—bronchus—allergic rhinitis	0.000168	0.0486	CbGeAlD
Tolazoline—HRH1—respiratory system—allergic rhinitis	0.000165	0.048	CbGeAlD
Tolazoline—HRH1—eye—allergic rhinitis	0.000151	0.0438	CbGeAlD
Tolazoline—ADRA2C—trachea—allergic rhinitis	0.00015	0.0436	CbGeAlD
Tolazoline—HRH1—epithelium—allergic rhinitis	0.000138	0.0401	CbGeAlD
Tolazoline—ADRA2A—bronchus—allergic rhinitis	0.000134	0.0388	CbGeAlD
Tolazoline—HRH1—trachea—allergic rhinitis	0.000122	0.0354	CbGeAlD
Tolazoline—ADRA2A—trachea—allergic rhinitis	0.00012	0.0348	CbGeAlD
Tolazoline—ADRA2C—lung—allergic rhinitis	0.000108	0.0313	CbGeAlD
Tolazoline—HRH1—lung—allergic rhinitis	8.78e-05	0.0255	CbGeAlD
Tolazoline—ADRA2A—lung—allergic rhinitis	8.63e-05	0.025	CbGeAlD
Tolazoline—HRH2—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	3.96e-06	0.0237	CbGpPWpGaD
Tolazoline—HRH2—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	3.4e-06	0.0203	CbGpPWpGaD
Tolazoline—HRH2—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	3.11e-06	0.0186	CbGpPWpGaD
Tolazoline—ADRA1A—AMPK Signaling—ADIPOQ—allergic rhinitis	2.71e-06	0.0162	CbGpPWpGaD
Tolazoline—HRH2—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	2.66e-06	0.0159	CbGpPWpGaD
Tolazoline—HRH2—GPCR ligand binding—PTGDR2—allergic rhinitis	2.59e-06	0.0154	CbGpPWpGaD
Tolazoline—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	2.57e-06	0.0154	CbGpPWpGaD
Tolazoline—ADRA2B—G alpha (i) signalling events—PTGDR2—allergic rhinitis	2.51e-06	0.015	CbGpPWpGaD
Tolazoline—HRH1—IL-4 Signaling Pathway—IL4—allergic rhinitis	2.47e-06	0.0147	CbGpPWpGaD
Tolazoline—ADRA2C—G alpha (i) signalling events—PTGDR2—allergic rhinitis	2.35e-06	0.014	CbGpPWpGaD
Tolazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	2.33e-06	0.0139	CbGpPWpGaD
Tolazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	2.18e-06	0.013	CbGpPWpGaD
Tolazoline—HRH2—GPCR ligand binding—CYSLTR1—allergic rhinitis	2.03e-06	0.0121	CbGpPWpGaD
Tolazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	2e-06	0.0119	CbGpPWpGaD
Tolazoline—HRH1—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	1.97e-06	0.0118	CbGpPWpGaD
Tolazoline—HRH2—GPCR ligand binding—CCL11—allergic rhinitis	1.96e-06	0.0117	CbGpPWpGaD
Tolazoline—HRH1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.94e-06	0.0116	CbGpPWpGaD
Tolazoline—ADRA1A—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	1.93e-06	0.0115	CbGpPWpGaD
Tolazoline—ADRA2A—G alpha (i) signalling events—PTGDR2—allergic rhinitis	1.91e-06	0.0114	CbGpPWpGaD
Tolazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.9e-06	0.0114	CbGpPWpGaD
Tolazoline—HRH2—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	1.87e-06	0.0112	CbGpPWpGaD
Tolazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.87e-06	0.0111	CbGpPWpGaD
Tolazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.83e-06	0.0109	CbGpPWpGaD
Tolazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.77e-06	0.0106	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	1.76e-06	0.0105	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	1.73e-06	0.0103	CbGpPWpGaD
Tolazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.71e-06	0.0102	CbGpPWpGaD
Tolazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.66e-06	0.00992	CbGpPWpGaD
Tolazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.63e-06	0.00973	CbGpPWpGaD
Tolazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.57e-06	0.00935	CbGpPWpGaD
Tolazoline—HRH1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.52e-06	0.00908	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—PTGDR2—allergic rhinitis	1.52e-06	0.00908	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.52e-06	0.00904	CbGpPWpGaD
Tolazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.51e-06	0.00903	CbGpPWpGaD
Tolazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.49e-06	0.00891	CbGpPWpGaD
Tolazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.46e-06	0.00874	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—PTGDR2—allergic rhinitis	1.46e-06	0.00872	CbGpPWpGaD
Tolazoline—HRH2—GPCR ligand binding—TAC1—allergic rhinitis	1.42e-06	0.0085	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—PTGDR2—allergic rhinitis	1.42e-06	0.00848	CbGpPWpGaD
Tolazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.41e-06	0.00844	CbGpPWpGaD
Tolazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.39e-06	0.00828	CbGpPWpGaD
Tolazoline—HRH1—G alpha (q) signalling events—TAC1—allergic rhinitis	1.38e-06	0.00825	CbGpPWpGaD
Tolazoline—ADRA1A—G alpha (q) signalling events—TAC1—allergic rhinitis	1.36e-06	0.00809	CbGpPWpGaD
Tolazoline—ADRA2B—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	1.35e-06	0.00806	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—PTGDR2—allergic rhinitis	1.33e-06	0.00792	CbGpPWpGaD
Tolazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.3e-06	0.00778	CbGpPWpGaD
Tolazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.28e-06	0.00764	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—PTGDR2—allergic rhinitis	1.27e-06	0.00755	CbGpPWpGaD
Tolazoline—ADRA2C—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	1.26e-06	0.00753	CbGpPWpGaD
Tolazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.26e-06	0.00752	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—PTGDR2—allergic rhinitis	1.24e-06	0.00741	CbGpPWpGaD
Tolazoline—HRH1—IL-4 Signaling Pathway—NFKB1—allergic rhinitis	1.24e-06	0.00741	CbGpPWpGaD
Tolazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.24e-06	0.00738	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	1.24e-06	0.00738	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	1.21e-06	0.00724	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—CYSLTR1—allergic rhinitis	1.19e-06	0.00712	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.19e-06	0.0071	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—PTGDR2—allergic rhinitis	1.15e-06	0.00689	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—CCL11—allergic rhinitis	1.15e-06	0.00688	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.15e-06	0.00685	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—CYSLTR1—allergic rhinitis	1.15e-06	0.00684	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—CYSLTR1—allergic rhinitis	1.11e-06	0.00665	CbGpPWpGaD
Tolazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	1.1e-06	0.00656	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—CCL11—allergic rhinitis	1.08e-06	0.00643	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.04e-06	0.00621	CbGpPWpGaD
Tolazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	1.03e-06	0.00613	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	1.02e-06	0.00612	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—CCL11—allergic rhinitis	1.01e-06	0.006	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—CYSLTR1—allergic rhinitis	9.93e-07	0.00593	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—CYSLTR1—allergic rhinitis	9.74e-07	0.00582	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—CCL11—allergic rhinitis	9.59e-07	0.00572	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—CCL11—allergic rhinitis	9.41e-07	0.00562	CbGpPWpGaD
Tolazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	9.15e-07	0.00546	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—CYSLTR1—allergic rhinitis	9.05e-07	0.0054	CbGpPWpGaD
Tolazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	8.98e-07	0.00536	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—CCL11—allergic rhinitis	8.74e-07	0.00522	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—PTGDR2—allergic rhinitis	8.59e-07	0.00513	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—TAC1—allergic rhinitis	8.37e-07	0.005	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	8.34e-07	0.00498	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—TAC1—allergic rhinitis	8.05e-07	0.0048	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—PTGDR2—allergic rhinitis	8.03e-07	0.00479	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—PTGDR2—allergic rhinitis	7.84e-07	0.00468	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—TAC1—allergic rhinitis	7.82e-07	0.00467	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—PTGDR2—allergic rhinitis	7.8e-07	0.00466	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—IL5—allergic rhinitis	7.48e-07	0.00446	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—TAC1—allergic rhinitis	7.31e-07	0.00436	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—PTGDR2—allergic rhinitis	7.29e-07	0.00435	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—PTGDR2—allergic rhinitis	7.15e-07	0.00427	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—PTGDR2—allergic rhinitis	7.02e-07	0.00419	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—TAC1—allergic rhinitis	6.97e-07	0.00416	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—IL5—allergic rhinitis	6.96e-07	0.00415	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—TAC1—allergic rhinitis	6.84e-07	0.00408	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—IL5—allergic rhinitis	6.79e-07	0.00405	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	6.74e-07	0.00402	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—PTGDR2—allergic rhinitis	6.52e-07	0.00389	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—IL5—allergic rhinitis	6.5e-07	0.00388	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—PTGDR2—allergic rhinitis	6.49e-07	0.00388	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—PTGDR2—allergic rhinitis	6.37e-07	0.0038	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—TAC1—allergic rhinitis	6.35e-07	0.00379	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—CYSLTR1—allergic rhinitis	6.3e-07	0.00376	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CYSLTR1—allergic rhinitis	6.15e-07	0.00367	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CYSLTR1—allergic rhinitis	6.12e-07	0.00365	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CCL11—allergic rhinitis	5.94e-07	0.00355	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PTGDR2—allergic rhinitis	5.92e-07	0.00353	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CCL11—allergic rhinitis	5.91e-07	0.00353	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CYSLTR1—allergic rhinitis	5.72e-07	0.00341	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.61e-07	0.00335	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CCL11—allergic rhinitis	5.52e-07	0.0033	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.51e-07	0.00329	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—IL5—allergic rhinitis	5.28e-07	0.00315	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.12e-07	0.00305	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CYSLTR1—allergic rhinitis	5.1e-07	0.00304	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CYSLTR1—allergic rhinitis	5e-07	0.00298	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CCL11—allergic rhinitis	4.92e-07	0.00294	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CCL11—allergic rhinitis	4.83e-07	0.00288	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—TAC1—allergic rhinitis	4.73e-07	0.00282	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CYSLTR1—allergic rhinitis	4.65e-07	0.00277	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PTGDR2—allergic rhinitis	4.61e-07	0.00275	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CCL11—allergic rhinitis	4.49e-07	0.00268	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—TAC1—allergic rhinitis	4.42e-07	0.00264	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—IL5—allergic rhinitis	4.4e-07	0.00263	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TAC1—allergic rhinitis	4.32e-07	0.00258	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PTGDR2—allergic rhinitis	4.31e-07	0.00257	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—TAC1—allergic rhinitis	4.3e-07	0.00256	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—IL5—allergic rhinitis	4.11e-07	0.00245	CbGpPWpGaD
Tolazoline—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	4.02e-07	0.0024	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—TAC1—allergic rhinitis	4.01e-07	0.0024	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IL5—allergic rhinitis	4.01e-07	0.00239	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—IL5—allergic rhinitis	4e-07	0.00238	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—TAC1—allergic rhinitis	3.94e-07	0.00235	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—TAC1—allergic rhinitis	3.86e-07	0.00231	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PTGDR2—allergic rhinitis	3.84e-07	0.00229	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PTGDR2—allergic rhinitis	3.76e-07	0.00225	CbGpPWpGaD
Tolazoline—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	3.76e-07	0.00224	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—IL5—allergic rhinitis	3.73e-07	0.00223	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—IL5—allergic rhinitis	3.66e-07	0.00218	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CYSLTR1—allergic rhinitis	3.62e-07	0.00216	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—IL5—allergic rhinitis	3.59e-07	0.00214	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—TAC1—allergic rhinitis	3.59e-07	0.00214	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—TAC1—allergic rhinitis	3.58e-07	0.00213	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—TAC1—allergic rhinitis	3.51e-07	0.00209	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PTGDR2—allergic rhinitis	3.5e-07	0.00209	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCL11—allergic rhinitis	3.49e-07	0.00209	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CYSLTR1—allergic rhinitis	3.38e-07	0.00202	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—IL5—allergic rhinitis	3.34e-07	0.00199	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—IL5—allergic rhinitis	3.32e-07	0.00198	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCL11—allergic rhinitis	3.26e-07	0.00195	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—IL5—allergic rhinitis	3.26e-07	0.00195	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—TAC1—allergic rhinitis	3.26e-07	0.00195	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	3.05e-07	0.00182	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—IL5—allergic rhinitis	3.03e-07	0.00181	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CYSLTR1—allergic rhinitis	3.01e-07	0.0018	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CYSLTR1—allergic rhinitis	2.95e-07	0.00176	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCL11—allergic rhinitis	2.91e-07	0.00174	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCL11—allergic rhinitis	2.85e-07	0.0017	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—SMAD3—allergic rhinitis	2.82e-07	0.00169	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CYSLTR1—allergic rhinitis	2.74e-07	0.00164	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCL11—allergic rhinitis	2.65e-07	0.00158	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TAC1—allergic rhinitis	2.54e-07	0.00152	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TAC1—allergic rhinitis	2.37e-07	0.00142	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL5—allergic rhinitis	2.36e-07	0.00141	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL5—allergic rhinitis	2.2e-07	0.00132	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TAC1—allergic rhinitis	2.11e-07	0.00126	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—TGFB1—allergic rhinitis	2.07e-07	0.00124	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TAC1—allergic rhinitis	2.07e-07	0.00124	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL5—allergic rhinitis	1.96e-07	0.00117	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—TGFB1—allergic rhinitis	1.94e-07	0.00116	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL5—allergic rhinitis	1.93e-07	0.00115	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TAC1—allergic rhinitis	1.93e-07	0.00115	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL5—allergic rhinitis	1.79e-07	0.00107	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SMAD3—allergic rhinitis	1.66e-07	0.000991	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—TGFB1—allergic rhinitis	1.57e-07	0.000939	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SMAD3—allergic rhinitis	1.55e-07	0.000926	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—NFKB1—allergic rhinitis	1.44e-07	0.000857	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SMAD3—allergic rhinitis	1.38e-07	0.000825	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SMAD3—allergic rhinitis	1.36e-07	0.00081	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SMAD3—allergic rhinitis	1.26e-07	0.000752	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TGFB1—allergic rhinitis	1.2e-07	0.000714	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NFKB1—allergic rhinitis	8.44e-08	0.000504	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NFKB1—allergic rhinitis	7.89e-08	0.000471	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TGFB1—allergic rhinitis	7.03e-08	0.00042	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NFKB1—allergic rhinitis	7.03e-08	0.000419	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NFKB1—allergic rhinitis	6.89e-08	0.000411	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TGFB1—allergic rhinitis	6.57e-08	0.000392	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NFKB1—allergic rhinitis	6.41e-08	0.000382	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TGFB1—allergic rhinitis	5.85e-08	0.000349	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TGFB1—allergic rhinitis	5.74e-08	0.000343	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TGFB1—allergic rhinitis	5.34e-08	0.000318	CbGpPWpGaD
